Business Wire

The newsfeed available here is provided by our content partner Business Wire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public. Business Wire is a subsidiary of the Warren Buffett Group Berkshire Hathaway.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 76
6.316,42 S&P · 18,88 Vola-Index · 119.392,91 BTC · 1,16386 EURUSD
System-State: Number of processed items 51.993 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
Business Wire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
US68622V1061
State: 21.07.2025 | 6AM
Do you already know our new terminal view? Click here.
FIGI: BBG00ZQRGW24
OGN
Organon & Co.
GICS: - · Sector: Healthcare · Sub-Sector: Drug Manufacturers - General
NAME
Organon & Co.
ISIN
US68622V1061
TICKER
OGN
MIC
XNYS
REUTERS
OGN.N
BLOOMBERG
OGN US
Sat, 19.07.2025       Organon & Co.
US68622V1061

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 22, 2025 to file lead plaintiff applications in securities class action lawsuits against Organon & Co. (NYSE: OGN), if they purchased the Company’s securities between November 3, 2022 an...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Wed, 09.07.2025       Organon & Co.
US68622V1061

Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, inclusive (the “Class Period”). Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action la...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Mon, 07.07.2025       Organon & Co.
US68622V1061

Organon (NYSE: OGN), a global independent healthcare company with a focus on women’s health, today announced that VTAMA® (tapinarof) cream, 1%, was granted a strong recommendation by the American Academy of Dermatology (AAD) in their 2025 focused guideline update for the management of adults with moderate to severe atopic dermatitis (AD). The reco...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Wed, 02.07.2025       Organon & Co.
US68622V1061

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced that the Phase 2 ELENA proof-of-concept study evaluating the investigational candidate OG-6219 in endometriosis-related pain did not meet its primary efficacy endpoint. OG-6219 is an oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor, whi...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Thu, 05.06.2025       Organon & Co.
US68622V1061

Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Wed, 04.06.2025       Organon & Co.
US68622V1061

Law Offices of Howard G. Smith reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Tue, 03.06.2025       Organon & Co.
US68622V1061

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”). Organon investors have until July 22, 2025 to file a lead plaintiff motion. IF...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Mon, 02.06.2025       Organon & Co.
US68622V1061

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Per...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Fri, 30.05.2025       Organon & Co.
US68622V1061

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”). Organon investors have until July 22, 2025 to file a lead plaintiff motion. IF Y...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Thu, 29.05.2025       Organon & Co.
US68622V1061

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ORGANON &am...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Thu, 29.05.2025       Organon & Co.
US68622V1061

Law Offices of Howard G. Smith announces an investigation on behalf of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORGANON & CO. (OGN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PU...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Thu, 29.05.2025       Organon & Co.
US68622V1061

The law firm of Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.) – seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon and certain of Organon’s executives with violations of the Securities Exc...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Thu, 29.05.2025       Organon & Co.
US68622V1061

The Law Offices of Frank R. Cruz announces an investigation of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ORGANON & CO. (OGN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO REC...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Wed, 28.05.2025       Organon & Co.
US68622V1061

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers of Organon & Co. (NYSE: OGN) securities between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”). Organon is a healthcare company. For more information, submit a form, email attorn...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Wed, 28.05.2025       Organon & Co.
US68622V1061

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfa...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Tue, 27.05.2025       Organon & Co.
US68622V1061

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Organon & Co. (NYSE: OGN) resulting from allegations that Organon may have issued materially misleading business information to the investing public. So What: If you purchased Organon securities you m...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Tue, 27.05.2025       Organon & Co.
US68622V1061

Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the HADLIMA™ (adalimumab-bwwd) high- and low-concentration (40 mg/0.4 mL, 40 mg/0.8 mL) autoinjectors and high-concentration prefilled syringe as interchangeable biosimilars to Humira® (adalimumab).2 These inter...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Tue, 27.05.2025       Organon & Co.
US68622V1061

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organon & Co. (“Organon” or “the Company”) (NYSE: OGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investo...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Tue, 27.05.2025       Organon & Co.
US68622V1061

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon & Co. (NYSE: OGN), if they purchased the Company’s securities between October 31, 2024 and A...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Mon, 26.05.2025       Organon & Co.
US68622V1061

The law firm of Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.) – seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon as well as certain of Organon’s executives with violations of the Securit...
Read More
Organon & Co.
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Tigo Energy
Tigo Energy Adds Solar-Plus-Storage Portfolio in Czech Republic to Build on MLPE Success
© BusinessWire
Faraday Future
YT Jia Shares Weekly Investor Update: Faraday X Unveils Two Groundbreaking Global-First Products Along with a Transformative Technology Architecture in Los Angeles on July 17
© BusinessWire
China Dev Bank Fin Leasing Co Ltd
CDB Aviation and Loong Air Execute Lease Agreements for Six A321neo Aircraft
© BusinessWire
CAVA Group
CAVA’s First Ever Michigan Restaurant Opens in Canton
© BusinessWire
Edgewise Therapeutics
EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
© BusinessWire
Altimmune
ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm
© BusinessWire
Unicycive Therapeutics
UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
© BusinessWire
WPP
WPP Investors Have Opportunity to Join WPP plc Fraud Investigation with the Schall Law Firm
© BusinessWire
Sarepta Therapeutics
Sarepta Therapeutics Provides Statement on ELEVIDYS
© BusinessWire
Century Aluminum
CENTURY ALUMINUM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Century Aluminum Co. - CENX
© BusinessWire
Inspirato
INSPIRATO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspirato Inc. - ISPO
© BusinessWire
Four Corners Property Trust
FCPT Announces Acquisition of Six Novant Health Urgent Care Properties for $12.0 Million
© BusinessWire
Block
Block Set to Join the S&P 500
© BusinessWire
GoodRx
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX
© BusinessWire
Chewy
CHEWY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Chewy, Inc. - CHWY
© BusinessWire
Capital One Financial
CAPITAL ONE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Capital One Financial Corporation - COF
© BusinessWire
Altice USA
ALTICE USA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Altice USA, Inc. - ATUS
© BusinessWire
Organon & Co.
ORGANON 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Organon & Co. - OGN
© BusinessWire
Red Cat
RED CAT 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Red Cat Holdings, Inc. - RCAT
© BusinessWire
Smith Micro Software
 Smith Micro Announces Closing of Follow-On Offering
© BusinessWire
New Germany Fund Inc
The New Germany Fund, Inc. Announces Results of the Fund’s Annual Meeting of Stockholders
© BusinessWire
Neogen
Grant & Eisenhofer Files Class Action Lawsuit Against Neogen Corporation
© BusinessWire
KB Home
KB Home Announces the Grand Opening of Its Newest Community in Highly Desirable Bothell, Washington
© BusinessWire
Delek Logistics
Delek Logistics Partners, LP to Host Second Quarter 2025 Conference Call on August 6th
© BusinessWire
Marcus Corp.
Marcus Corporation Announces Second Quarter Fiscal 2025 Release Date and Conference Call
© BusinessWire

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.

 

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S